• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

N-[4-(1H-吡唑并[3,4-b]吡嗪-6-基)苯基]磺酰胺作为高活性和选择性SGK1抑制剂的发现。

Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 Inhibitors.

作者信息

Halland Nis, Schmidt Friedemann, Weiss Tilo, Saas Joachim, Li Ziyu, Czech Jörg, Dreyer Matthias, Hofmeister Armin, Mertsch Katharina, Dietz Uwe, Strübing Carsten, Nazare Marc

机构信息

Sanofi R&D , Industriepark Höchst Building G838, D-65926 Frankfurt am Main, Germany.

Leibniz-Institut für Molekulare Pharmakologie (FMP) , Robert-Rössle-Straße 10, 13125 Berlin-Buch, Germany.

出版信息

ACS Med Chem Lett. 2014 Oct 23;6(1):73-8. doi: 10.1021/ml5003376. eCollection 2015 Jan 8.

DOI:10.1021/ml5003376
PMID:25589934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4291729/
Abstract

From a virtual screening starting point, inhibitors of the serum and glucocorticoid regulated kinase 1 were developed through a combination of classical medicinal chemistry and library approaches. This resulted in highly active small molecules with nanomolar activity and a good overall in vitro and ADME profile. Furthermore, the compounds exhibited unusually high kinase and off-target selectivity due to their rigid structure.

摘要

从虚拟筛选出发，通过经典药物化学和文库方法相结合，开发了血清和糖皮质激素调节激酶1的抑制剂。这产生了具有纳摩尔活性且体外和ADME性质良好的高活性小分子。此外，由于其刚性结构，这些化合物表现出异常高的激酶和脱靶选择性。

相似文献

1
Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 Inhibitors.N-[4-(1H-吡唑并[3,4-b]吡嗪-6-基)苯基]磺酰胺作为高活性和选择性SGK1抑制剂的发现。
ACS Med Chem Lett. 2014 Oct 23;6(1):73-8. doi: 10.1021/ml5003376. eCollection 2015 Jan 8.
2
Unlocking SGK1 inhibitor potential of bis-[1-N,7-N, pyrazolo tetraethoxyphthalimido{-4-(3,5-Dimethyl-4-(spiro-3-methylpyazolo)-1,7-dihydro-1H-dipyrazolo[3,4-b;4',3'-e]pyridin-8-yl)}]p-disubstituted phenyl compounds: a computational study.解锁双-[1-N,7-N, 吡唑并四乙氧基邻苯二甲酰亚胺基{-4-[3,5-二甲基-4-(螺-3-甲基吡唑并[3,4-b;4',3'-e]吡啶-8-基)]二取代苯基}]化合物对 SGK1 抑制剂的潜力：计算研究。
J Biomol Struct Dyn. 2022;40(24):13412-13431. doi: 10.1080/07391102.2021.1988711. Epub 2021 Oct 25.
3
Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of cancer.发现一类新型的高度选择性间质-上皮转化因子（c-MET）蛋白激酶抑制剂，并鉴定出临床候选药物 2-(4-(1-(6-喹啉基甲基)-1H-[1,2,3]三唑并[4,5-b]吡嗪-6-基)-1H-吡唑-1-基)乙醇（PF-04217903），用于癌症治疗。
J Med Chem. 2012 Sep 27;55(18):8091-109. doi: 10.1021/jm300967g. Epub 2012 Sep 10.
4
Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors.口服生物可利用的血清和糖皮质激素调节激酶1（SGK1）抑制剂的设计与合成。
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4441-5. doi: 10.1016/j.bmcl.2009.05.051. Epub 2009 May 18.
5
From Type I to Type II: Design, Synthesis, and Characterization of Potent Pyrazin-2-ones as DFG-Out Inhibitors of PDGFRβ.从I型到II型：强效吡嗪 - 2 - 酮作为血小板衍生生长因子受体β（PDGFRβ）DFG-out抑制剂的设计、合成与表征
ChemMedChem. 2016 Dec 16;11(24):2664-2674. doi: 10.1002/cmdc.201600494. Epub 2016 Nov 25.
6
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold.基于吡唑并嘧啶骨架的新型选择性血清/糖皮质激素诱导激酶1抑制剂的计算机模拟鉴定与生物学评价
J Chem Inf Model. 2014 Jul 28;54(7):1828-32. doi: 10.1021/ci500235f. Epub 2014 Jun 13.
7
Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library.通过聚焦蛋白激酶文库的表型筛选发现布氏锥虫抑制剂
ChemMedChem. 2015 Nov;10(11):1809-20. doi: 10.1002/cmdc.201500300. Epub 2015 Sep 18.
8
Crystal structure of 5-(4,5-di-hydro-1H-imidazol-2-yl)-3-methyl-1-phenyl-1H-pyrazolo-[3,4-b]pyrazin-6-amine.5-（4,5-二氢-1H-咪唑-2-基）-3-甲基-1-苯基-1H-吡唑并[3,4-b]吡嗪-6-胺的晶体结构
Acta Crystallogr Sect E Struct Rep Online. 2014 Oct 31;70(Pt 11):o1212-3. doi: 10.1107/S160053681402354X. eCollection 2014 Nov 1.
9
Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.基于共有特征药效团模型的虚拟筛选和从头优化发现新型 CK1 抑制剂 N6-苯基-1H-吡唑并[3,4-d]嘧啶-3,6-二胺衍生物。
Eur J Med Chem. 2012 Oct;56:30-8. doi: 10.1016/j.ejmech.2012.08.007. Epub 2012 Aug 14.
10
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4.5-氨基-N-(1H-吡唑-4-基)吡唑并[1,5-a]嘧啶-3-甲酰胺类IRAK4抑制剂的发现
ACS Med Chem Lett. 2015 Apr 20;6(6):683-8. doi: 10.1021/acsmedchemlett.5b00107. eCollection 2015 Jun 11.

引用本文的文献

1
Discovery of a brain penetrant SGK1 inhibitor using a ligand- and structure-based virtual screening methodology.使用基于配体和结构的虚拟筛选方法发现一种可穿透血脑屏障的SGK1抑制剂。
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2546591. doi: 10.1080/14756366.2025.2546591. Epub 2025 Aug 29.
2
Unraveling the Potential of SGK1 in Osteoporosis: From Molecular Mechanisms to Therapeutic Targets.揭示SGK1在骨质疏松症中的潜力：从分子机制到治疗靶点
Biomolecules. 2025 May 8;15(5):686. doi: 10.3390/biom15050686.
3
Decoding the role of glucocorticoid-regulated kinase 1 in Alzheimer's disease: a promising path toward novel therapeutic strategies.解读糖皮质激素调节激酶1在阿尔茨海默病中的作用：通向新型治疗策略的一条充满希望的途径。
Inflammopharmacology. 2025 May 15. doi: 10.1007/s10787-025-01777-z.
4
Distinct phases of cellular signaling revealed by time-resolved protein synthesis.时间分辨蛋白质合成揭示细胞信号的不同阶段。
Nat Chem Biol. 2024 Oct;20(10):1353-1360. doi: 10.1038/s41589-024-01677-3. Epub 2024 Jul 8.
5
AGC kinase inhibitors regulate STING signaling through SGK-dependent and SGK-independent mechanisms.AGC 激酶抑制剂通过 SGK 依赖和非依赖机制调节 STING 信号通路。
Cell Chem Biol. 2023 Dec 21;30(12):1601-1616.e6. doi: 10.1016/j.chembiol.2023.10.008. Epub 2023 Nov 7.
6
An overview of PROTACs: a promising drug discovery paradigm.蛋白水解靶向嵌合体（PROTACs）概述：一种前景广阔的药物发现模式。
Mol Biomed. 2022 Dec 20;3(1):46. doi: 10.1186/s43556-022-00112-0.
7
Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors.血清和糖皮质激素调节激酶1：结构、生物学功能及其抑制剂
Front Pharmacol. 2022 Nov 15;13:1036844. doi: 10.3389/fphar.2022.1036844. eCollection 2022.
8
Identification of Novel Inhibitors Targeting SGK1 via Ensemble-Based Virtual Screening Method, Biological Evaluation and Molecular Dynamics Simulation.通过基于集成的虚拟筛选方法、生物评价和分子动力学模拟鉴定靶向 SGK1 的新型抑制剂。
Int J Mol Sci. 2022 Aug 3;23(15):8635. doi: 10.3390/ijms23158635.
9
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.HER2+ 乳腺癌中耐药休眠细胞的个体发生和脆弱性。
Cancer Discov. 2022 Apr 1;12(4):1022-1045. doi: 10.1158/2159-8290.CD-20-1265.
10
Serum- and glucocorticoid-inducible kinase 1 activity in ventral tegmental area dopamine neurons regulates cocaine conditioned place preference but not cocaine self-administration.腹侧被盖区多巴胺神经元中血清和糖皮质激素诱导激酶 1 的活性调节可卡因条件性位置偏爱，但不调节可卡因自我给药。
Neuropsychopharmacology. 2021 Aug;46(9):1574-1583. doi: 10.1038/s41386-021-01032-3. Epub 2021 May 18.

本文引用的文献

1
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold.基于吡唑并嘧啶骨架的新型选择性血清/糖皮质激素诱导激酶1抑制剂的计算机模拟鉴定与生物学评价
J Chem Inf Model. 2014 Jul 28;54(7):1828-32. doi: 10.1021/ci500235f. Epub 2014 Jun 13.
2
PKB/SGK-resistant GSK-3 signaling following unilateral ureteral obstruction.单侧输尿管梗阻后 PKB/SGK 抵抗的 GSK-3 信号传导。
Kidney Blood Press Res. 2013;38(1):156-64. doi: 10.1159/000355763. Epub 2014 Mar 15.
3
Predictive in silico off-target profiling in drug discovery.药物发现中的预测性计算机筛选脱靶分析。
Future Med Chem. 2014 Mar;6(3):295-317. doi: 10.4155/fmc.13.202.
4
Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683.选择性SGK抑制剂EMD638683对结肠肿瘤生长的抑制作用
Cell Physiol Biochem. 2013;32(4):838-48. doi: 10.1159/000354486. Epub 2013 Sep 20.
5
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis.SGK1 激酶在应激、抑郁和糖皮质激素对海马神经发生影响中的作用。
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8708-13. doi: 10.1073/pnas.1300886110. Epub 2013 May 6.
6
Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening.从虚拟筛选中鉴定新型血清和糖皮质激素调节激酶-1 (SGK1) 配体。
Bioorg Med Chem Lett. 2012 Sep 1;22(17):5675-8. doi: 10.1016/j.bmcl.2012.06.096. Epub 2012 Jul 15.
7
Testing the promiscuity of commercial kinase inhibitors against the AGC kinase group using a split-luciferase screen.利用荧光素酶报告基因筛选检测商业激酶抑制剂对 AGC 激酶组的非选择性抑制作用。
J Med Chem. 2012 Feb 23;55(4):1526-37. doi: 10.1021/jm201265f. Epub 2012 Feb 10.
8
Epithelial sodium channel regulation by cell surface-associated serum- and glucocorticoid-regulated kinase 1.细胞表面相关的血清和糖皮质激素调节激酶 1 对上皮钠离子通道的调节。
J Biol Chem. 2011 Sep 16;286(37):32074-85. doi: 10.1074/jbc.M111.278283. Epub 2011 Jul 22.
9
Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes.丝氨酸/苏氨酸蛋白激酶 SGK1 在糖皮质激素依赖性胰腺腺泡细胞向肝细胞转分化中的作用。
J Cell Sci. 2011 Feb 1;124(Pt 3):405-13. doi: 10.1242/jcs.077503. Epub 2011 Jan 11.
10
Stimulation of Na+/K+ ATPase activity and Na+ coupled glucose transport by β-catenin.β-连环蛋白刺激 Na+/K+ATP 酶活性和 Na+偶联葡萄糖转运。
Biochem Biophys Res Commun. 2010 Nov 19;402(3):467-70. doi: 10.1016/j.bbrc.2010.10.049. Epub 2010 Oct 14.